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The synthesis of the quinoline alkaloid atanine 6, by selective demethylation of the 2,4-dimethoxyquinoline 11 is presented.  An 
alternative demethylation utilising a thiolate anion leads to the regioisomeric 4-hydroxyquinoline 13. 
                                                          
 
Introduction 
The Rutaceae family of plants is the source of over 500 alkaloids 
containing the quinoline ring system.1,2  The pharmacological 
properties of this class of compounds have received only limited 
investigation.  Nevertheless, a wide range of medicinal 
properties has already been identified including anti-protozoal, 3 
anti-bacterial, 4 anti-fungal5 and anti-viral6 activities.  Among the 
compounds isolated from Rutaceae, a range of structural types is 
identifiable.  These include the furanoquinolines such as 
dictamine 1, the dihydrofuranoquinolines such as platydesmine 
2, the isomeric dihydrofuranoquinolines such as araliopsine 3, 
the dihydropyranoquinolines such as geibalansine 4, the isomeric 
dihydropyranoquinolines such as ψ-ribalinine 5 and the simple 
2,4-dioxygenated quinolines such as atanine 6 (fig. 1).  Atanine 
was first isolated in 19687 although it had been postulated to be a 
plausible biosynthetic intermediate of the quinoline alkaloids 
prior to its isolation.  Since 1968, it has been found in many 
members of the Rutaceae family and its biosynthetic 
involvement has been demonstrated. 8  Our interest in this area 
was triggered by the discovery of atanine in Evodia rutaecarpa 
and the demonstration of its anthelmintic activity particularly 
against Schistosoma mansoni. 9  As a consequence, we required 
quantities of atanine and structurally related compounds for 
testing against a range of parasites.  The first synthesis of atanine 
was reported by Grundon in 1966 and involved treatment of 4-
hydroxyquinoline 7 with diazomethane to give atanine 6 in 80% 
yield (scheme 1). 10  This approach has recently been used by 
Boyd in an investigation into the absolute configuration of 
several of the alkaloids referred to above. 11  In 1973, Grundon 
published an alternative synthesis of atanine which avoided 
diazomethane and involved ortholithiation of 2,4-
dimethoxyquinoline 8, alkylation with prenyl bromide and 
selective demethylation at the 4-position using dry HCl gas in di-
isopropyl ether (scheme 2). 12  This latter approach appeared 
ideal for our purposes. 
Results and Discussion 
Reaction of aniline with malonic acid in an excess of phosphorus 
oxychloride at reflux to give 2,4-dichloroquinoline 9 was first 
reported by Ziegler and Gelfert. 13  Although a reaction time of 
24 to 40 hours has been reported, we found that the best yield of 
9 (48%) was obtained after only 5 hours at reflux (scheme 3).  
Reaction of 2,4-dichloroquinoline 9 with sodium methoxide at 
reflux for 24 hours gave 2,4-dimethoxyquinoline 8 in 70% yield 
along with some 12% of 4-chloro-2-methoxyquinoline 10.  
Substitution at C-2 is known to be favoured kinetically and the 
second substitution is slowed considerably by the methoxy group 
at C-2 making bis-substitution difficult to drive to completion. 14  
Ortho-lithiation of 8 using n-butyllithium at 0 °C and addition of 
excess prenyl bromide gave the desired 3-alkylated quinoline 11 
in 88% yield.  However, reaction with dry HCl in di-isopropyl 
ether failed to give any atanine 6.  A range of conditions was 
investigated without success.  The reaction was repeated (in 
CDCl3) in an nmr tube.  After a very short period, the alkene 
proton at δ5.22 disappeared strongly suggesting that the fastest 
reaction was addition of HCl to the double bond of the sidechain.  
Reaction with various dilute mineral acids gave complex 
mixtures of products from which no atanine could be isolated. 
 
At this point we chose to explore an alternative strategy in which 
2,4-dimethoxyquinoline 8 was selectively demethylated to give 
12 followed by ortholithiation and alkylation to give atanine 6 
(scheme 3).  Treatment of 8 with dry HCl in di-isopropyl ether at 
reflux for 4 hours led to no reaction and starting material was 
isolated.  The lack of nucleophilicity of the chloride ion was felt 
to be the problem and so we used HBr instead.  Treatment of 8 
with 48% HBr led to double demethylation but reaction with 3% 
HBr in a 1:1 mixture of THF and water at reflux for 3 hours gave 
54% of 12 along with some 40% of starting material 8.  Reaction 
of 12 with 2 equivalents of n-butyllithium at –78 °C followed by 
addition of prenyl bromide gave atanine 6 but in only 3% yield 
along with starting material and decomposition products.  The 
use of prenyl triflate in place of prenyl bromide led to similar 
results.  Clearly this was not a viable method for the synthesis of 
atanine and analogues and so we turned our attention back to the 
selective demethylation of 11. 
 
Boron tribromide is well known to demethylate aromatic methyl 
ethers and being a Lewis acid should avoid problems of addition 
to the double bond in the sidechain.  Treatment of 11 with boron 
tribromide gave an intractable red solid that could not be 
characterised.  This appeared to confirm the sensitivity of the 
side chain to acid.  A non-acidic approach was investigated using 
thiolate ion, which is known to cleave aryl methyl ethers in 
solvents such as DMF. 15  Treatment of 11 with sodium isopropyl 
thiolate in DMF at reflux, gave 13 in 38% yield after 
chromatography (scheme 3).  The structure of 13 was assigned 
on the basis that the spectral data differed from the published 
data for atanine and that a correlation between the O-H proton at 
δ11.5 and the C-5 proton at δ7.98 was observed in the NOESY 
spectrum.  Presumably, this reaction proceeds via an SN2 process 
and favours 4-demethylation as the leaving group from this site 
of attack is more stable owing to greater charge delocalisation.  
On the basis of this result, trimethylsilyl iodide (TMSI) was 
explored as we felt the first step in the reaction of TMSI with 
quinoline 11 would be silylation of the nitrogen in a manner 
similar to protonation.  In order to prevent addition of a proton 
(from any HI either in the reagent or generated in the reaction) to 
the double bond, one equivalent of pyridine was added along 
1 
CREATED USING THE RSC ARTICLE TEMPLATE - SEE WWW.RSC.ORG/ELECTRONICFILES FOR FURTHER DETAILS 
with the TMSI.  To our delight stirring 11 with TMSI and 
pyridine in dry dichloromethane at –78 °C to room temperature 
gave a 2:1 mixture (as determined by 1H nmr) of atanine 6 and 
pyranoquinoline 1416 formed by protonation of the sidechain 
double bond and subsequent cyclisation onto the 2-quinolone 
oxygen.  The reaction was repeated using the stronger base 4-
(dimethylamino)pyridine (DMAP) and atanine 6 was obtained in 
62% yield after recrystallisation.  The spectroscopic data of the 
synthetic material matched that of the material isolated from 
Evodia fruits.9
 
In summary, we have clarified the synthesis of atanine 6 via 
ortholithiation/demethylation and have developed the 
TMSI/DMAP reagent system for the demethylation of such acid-
sensitive aryl methyl ethers.  We have also been able to 
synthesise selectively via thiolate promoted demethylation the 
regioisomer 13 of atanine. 
Experimental17
2,4-Dichloroquinoline, 9 
Aniline (6.7 g, 72 mmol) and malonic acid (11.7 g, 112 mmol) 
were heated under reflux in phosphorus oxychloride (60 ml), 
with stirring, for 5 hours.  The mixture was cooled, poured into 
crushed ice with vigorous stirring and then made alkaline with 
5M sodium hydroxide.  Filtration gave the crude product as a 
brown solid.  A four hour continuous (Soxhlet) extraction with 
hexane followed by evaporation of solvent under reduced 
pressure yielded a pale yellow powder.  Column chromatography 
(95:5 hexane:EtOAc ) yielded the pure dichloroquinoline as off-
white needles (6.8 g, 48%), mp 66-67 °C(lit.18 66 °C); Rf (95:5 
hexane:EtOAc ) 0.51; νmax /cm-1:  1580 (s, C=N); δH 8.18 (1H, 
dd, J 8.4, 1.3, H-5), 8.03 (1H, dd, J 8.5, 1.0, H-8),  7.79 (1H, 
ddd, J 8.5, 7.0, 1.3, H-7),  7.65, (1H, ddd, J 8.4, 7.0, 1.0, H-6),  
7.50 (1H, s, H-3); δC 149.8 (C-2), 148.1 (C-8a), 144.4 (C-4), 
131.5 (C-7), 129.0 (C-8), 127.9 (C-6), 125.2 (C-4a), 124.2 (C-5), 
121.9 (C-3); m/z: 201 (15%, M+ 
37
Cl2),  199 (72, M+ 
37
Cl
35
Cl),  
197 (100, M+ 
35
Cl2),  162 (69, M+ - Cl) (Found: M+(
35Cl2) 
196.9792.  C9H5
35Cl2N requires 196.9799).  
 
2,4-Dimethoxyquinoline, 8 and 4-chloro-2-methoxyquinoline, 
10 
2,4-Dichloroquinoline (2.8 g, 14 mmol) was heated under reflux 
in methanolic sodium methoxide solution (from 2.0 g, 86 mmol 
Na in 50 mL MeOH) for 24 hours.  The reaction mixture was 
cooled and poured into ice-cold water, and the resulting white 
precipitate was filtered off.  Column chromatography (9:1 
hexane:EtOAc) yielded the two products 
2,4-dimethoxyquinoline, (1.85 g, 70%) and 4-chloro-2-
methoxyquinoline, (0.32 g, 12%), both as white needles. 
2,4-dimethoxyquinoline, mp 78-80 °C (lit.19 81-82°C); Rf (9:1 
hexane:EtOAc ) 0.48; νmax /cm-1: 1640, 1580  (s, C=C, C=N); δH 8.04 (1H, dd, J 8.2, 1.5, H-5), 7.78 (1H, dd, J 8.5, 1.2, H-8), 
7.60 (1H, ddd, J 8.5, 7.0, 1.5, H-7), 7.33 (1H, ddd, J 8.2, 7.0, 1.2, 
H-6),  6.21(1H, s, H-3),  4.05 (3H, s, 2-OMe),  3.97 (3H, s, 4-
OMe); δC 163.9 (C-4), 163.84 (C-2), 147.1 (C-8aC, 130.0 (C-7), 
126.9 (C-8), 123.3 (C-6), 121.8 (C-5), 119.3 (C-4a), 90.7 (C-3), 
55.7 (4-OMe), 53.4 (2-OMe); m/z 189 (100%, M+), 188 (93, M+ 
- H) (Found: M+ 189.0797.  C11H11NO2 requires 189.0790). 
4-chloro-2-methoxyquinoline, mp 70-72 °C (lit.19 70-71°C); Rf 
(9:1 hexane:EtOAc ) 0.61; νmax /cm-1: 1610, 1580 (s, C=N and 
C=C); δH 8.10 (1H, dd, J 8.2, 1.3, H-5), 7.86 (1H, dd, J 8.0, 1.2, 
H-8), 7.67 (1H, ddd, J 8.0, 7.0, 1.3, H-7), 7.46 (1H, ddd, J 8.2, 
7.0, 1.2, H-6), 7.03 (1H, s, H-3), 4.06 (3H, s, -OCH3); δC 161.9 
(C-2), 147.0 (C-8a), 143.7 (C-4), 130.5 (C-7), 127.6 (C-8),  
124.8 (C-6), 124.1 (C-5), 123.3 (C-4a), 112.9 (C-3), 53.8 
(OCH3); m/z 195 (33%, M+ 
37
Cl), 193 (100, M+ 
35
Cl), 192 (67, 
M+ 
35
Cl -  H), 163 (33, M+ - CH2O) (Found M+: 193.0298.  
C10H8
35
ClNO requires 193.0294) 
 
2,4 -Dimethoxy-3-(3methylbut-2-enyl)quinoline, 11 
2,4-Dimethoxyquinoline (2.0 g, 11 mmol) in dry THF (10 ml) 
was cooled to 0 °C under argon and n-butyllithium (6.2 ml of a 
2.5M solution in hexane) was added dropwise, with stirring.  The 
mixture was stirred at 0 °C under argon for 30 minutes, then 1-
bromo-3-methylbut-2-ene (2.8 g, 19 mmol) was added dropwise 
over 5 minutes.  The mixture was stirred at 0 °C for 30 minutes 
and then allowed to warm to room temperature with stirring for a 
further hour.  The reaction mixture was poured into water and 
extracted with ether (4 × 30 ml) to give the crude product as a 
yellow/brown oil.  Column chromatography (4:1 hexane:EtOAc) 
yielded the pure product as a yellow-brown oil (2.4 g, 88%); Rf 
(4:1 hexane:EtOAc ) 0.57; νmax /cm-1:  3070 (s, C-H), 1620, 
1605, 1575 (s, C=C and C=N); δH 7.92 (1H, ddd, J 8.2, 1.5, 0.5, 
H-5), 7.82 (1H, ddd, J 8.5, 1.2, 0.5, H-8), 7.56 (1H, ddd, J 8.5, 
6.9, 1.5, H-7), 7.35 (1H, ddd, J 8.2, 6.9, 1.2, H-6), 5.22 (1H, br t, 
J 6.9, C=CH), 4.08 (3H, s, 2-OMe), 3.95 (3H, s, 4-OMe), 3.45 
(2H, d, J 6.9, CH2), 1.81 (3H, d, J 0.7, =CCH3), 1.69 (3H, d, J 
1.2, =CCH3); δC 162.5 (C-4), 161.6 (C-2), 146.1 (C-8a), 132.3 
(=CMe2), 128.9, 127.3, (C-7, C-8) 123.6, 121.9, 121.8, (C-5, C-
6 and =CH), 121.2 (C-3), 116.9 (C-4a), 62.3 (OMe), 53.8 
(OMe), 25.8 (CH3), 23.3 (CH2), 18.0 (CH3); m/z 257 (100%, 
M+), 242 (82, M+- Me), 202 (52, M+ - Me2C=CH) (Found: M+ 
257.1417.  C16H19NO2 requires 257.1416). 
 
4-Methoxy-1H-quinolin-2-one, 12 
2,4-Dimethoxyquinoline (2.0 g, 11 mmol) was dissolved in 3%  
HBr in a 1:1 mixture of H2O/THF (100 ml).  The solution was 
heated under reflux for 3 hours, then cooled and neutralised with 
aqueous NaHCO3.  The THF was removed under reduced 
pressure, precipitating a white solid, which was filtered and dried 
under suction.  Tlc (4:1 hexane:EtOAc) showed the presence of 
starting material and a polar material (baseline).  A 5 hour 
Soxhlet extraction with hexane separated these two compounds.  
The starting material was extracted into the reaction flask 
leaving the product as cream needles in the thimble (1.0 g, 54%), 
mp 249-252 °C (lit.21 250-253 °C); νmax /cm-1: 3100 (w, N-H),  
1674 (s, C=O),  1634, 1607 (s, C=C); δH 7.90 (1H, dd, J 8.1, 1.1, 
H-5), 7.52 (1H, dd, J 8.1, 1.1, H-7), 7.40 (1H, dd, J 8.1, 1.1, H-
8), 7.20 (1H, dd, J 8.1, 1.1, H-6), 6.03 (1H, s, H-3), 3.99 (3H, s, 
OMe); δC 166.3 (C-2), 165.0 (C-4), 138.4 (C-8a), 131.2 (C-7), 
122.8 (C-8), 122.2 (C-6), 116.1 (C-5), 115.6 (C-4a), 96.0 (C-3), 
56.0 (O-Me); m/z 175 (100%, M+), 132 (63, M+ - CONH), 76 
(28, C6H4+) (Found M+: 175.0629. C10H9NO2 requires 
175.0633). 
 
 
4-Hydroxy-2-methoxy 3-(3-methylbut-2-enyl)quinoline, 13 
Sodium hydride (0.67 g of a 60% mineral oil dispersion, washed 
with hexane, 17 mmol) was suspended in dimethylformamide 
(10 ml).  2-Propanethiol (0.51 g, 6.7 mmol) was added and the 
mixture was stirred for 10 minutes.  Then a solution of 2,4-
dimethoxy-3-(3-methylbut-2-enyl)quinoline (0.7 g, 2.7 mmol) in 
DMF (10 ml) was added, and the mixture heated under reflux for 
4 hours.  After cooling and neutralisation with 2M HCl the 
solution was extracted with ether (4 × 50 ml), the combined 
ether extracts were dried over MgSO4 , and the solvent removed 
in vacuo to give a brown oil.  Column chromatography (4:1 
hexane:ethyl acetate) followed by recrystallisation (ethanol) 
yielded the pure product (0.25 g, 38%) as off-white needles,  mp 
154-155 °C (lit.22 137-138 °C); Rf (4:1 hexane:EtOAc) 0.30; νmax /cm-1: 3200-3000 (br, O-H), 1627, 1580 (s, C=C, C=N); δH 7.98 (1H, dd, J 8.2, 1.3, H-5), 7.75 (1H, dd, J 8.2, 1.2, H-8), 
7.56 (1H, ddd, J 8.3, 6.9, 1.3, H-7), 7.32 (1H, ddd, J 8.2, 6.9, 1.2,  
H-6), 5.38 (1H, tq, J 7.3, 1.2, CH=), 4.06 (3H, s, OCH3), 3.51 
(2H, d, J 7.3, CH2CH=), 1.86 (3H, s, CH=CCH3 ), 1.81 (3H, d, 
J 1.2,  CH=CCH3), OH not observed in CDCl3; NOESY (d6 
DMSO) correlation between the OH proton at δ11.5 ppm and the 
C-5 proton at δ7.98 ppm; δC 161.4 (C-2), 145.0 (C-8a), 137.0 
(=C(CH3)2), 129.3, 126.5, 123.2, 121.6, 121.1 (C-5,-6,-7,-8 and 
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=CH), 119.0 (C-4a), 105.2 (C-3), 53.9 (OMe), 25.9 (CH3), 23.0 
(CH2), 18.0 (CH3), no signal observed for C4; m/z 243 (26%, 
M+), 228 (12, M+ - CH3), 188 (5% M+ - CH=C(CH3)2 ), 83 
(100) (Found: M+ 243.1246.  C15H17NO2 requires 243.1259). 
20 K. Shichiri, K. Funakoshi, S. Saeki, M. Hamana, Chem. Pharm. 
Bull., 1980, 28, 493-499. 
21 K. Nickisch, W. Klose, E. Nordhoff, F. Bohlmann, Chem. Ber., 
1980, 113, 3086-3088. 
22 J. Motoyoshiya, A. Takagi, K. Hirakawa, T. Kakurai, J. 
Heterocyclic Chem., 1986, 23, 597-599.  4-Methoxy-3-(3-methylbut-2-enyl)-1H-quinolin-2-one 
(atanine), 6 
 
2,4-Dimethoxy-3-(3-methylbut-2-enyl)quinoline (0.50 g, 2.0 
mmol) and 4-dimethylaminopyridine (0.24 g, 2.0 mmol) were 
dissolved in dry dichloromethane (30 ml) and cooled to –78 °C 
under argon.  Iodotrimethylsilane (0.40 g, 2.0 mmol) was added 
dropwise, and the mixture stirred at –78 °C for 2 hours.  Then 
the flask was left to warm to room temperature, with stirring, for 
a further 40 hours.  The solution obtained was washed with 1M 
aqueous sodium thiosulfate (2 × 30 ml), and then dried (MgSO4) 
and the solvent removed under reduced pressure.  A brown oil 
was obtained which crystallised overnight to give a pale brown 
solid.  Recrystallisation (EtOH) gave the title compound as off-
white needles (0.3 g, 62%), mp 130-132 °C (lit.12 132-134 °C)  
(Found: C, 72.44, H, 6.87, N, 5.69. C15H17NO2.0.3H2O requires 
C, 72.44, H, 7.13, N, 5.63%); νmax / cm-1 3250 (w, N-H), 1653 
(s, C=O), 1568 (m, C=C); δH 12.11 (1H, br s, NH/OH), 7.76 
(1H, dd, J 8.1, 1.2, H-5), 7.47 (1H, ddd, J 8.2, 7.0, 1.2, H-7), 
7.42 (1H, dd, J 8.2, 1.2, H-8), 7.22 (1H, ddd, J 8.1, 7.0, 1.2, H-
6), 5.32 (1H, t, J 6.9, CH=CMe2), 3.95 (3H, s, OMe), 3.45 (2H, 
d, J 6.9, CH2-CH=CMe2), 1.86 (3H, s, CH3), 1.71 (3H, s, 
CH3); δC 165.9 (C-2), 162.1 (C-4), 137.6, 132.5 (C-8a, 
C=CMe2), 130.0 (CH), 122.8 (CH), 122.6, 122.2 (CH), 121.6 
(CH), 117.2, 116.1 (CH), 61.8 (OCH3), 25.8 (CH=C(CH3)2), 
23.5 (C'H2), 18.1 (CH=C(CH3)2); m/z 243 (89%, M+), 228 (39, 
M+ - OMe), 188 (100, C11H10NO2+) (Found: M+ 243.1252.  
C15H17NO2 requires 243.1259). 
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Fig. 1 Representative quinoline alkaloids. 
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Scheme 3 
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